| Primary |
| Atrial Fibrillation |
46.1% |
| Hypertension |
13.5% |
| Cerebrovascular Accident Prophylaxis |
11.4% |
| Thrombosis Prophylaxis |
3.0% |
| Diabetes Mellitus |
2.8% |
| Cardiac Failure |
2.8% |
| Coronary Artery Disease |
2.8% |
| Pain |
2.0% |
| Prophylaxis |
2.0% |
| Anticoagulant Therapy |
1.8% |
| Hyperlipidaemia |
1.8% |
| Hypercholesterolaemia |
1.7% |
| Deep Vein Thrombosis |
1.4% |
| Heart Rate Abnormal |
1.2% |
| Hypothyroidism |
1.1% |
| Transient Ischaemic Attack |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Pulmonary Embolism |
1.0% |
| Cardiac Failure Congestive |
0.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.9% |
|
| Haemorrhage |
9.8% |
| Dyspepsia |
8.6% |
| Gastrointestinal Haemorrhage |
8.3% |
| Rectal Haemorrhage |
7.7% |
| Pulmonary Embolism |
7.4% |
| Ischaemic Stroke |
6.5% |
| Vomiting |
6.2% |
| Deep Vein Thrombosis |
5.5% |
| Cerebrovascular Accident |
4.9% |
| Gastric Haemorrhage |
4.9% |
| Anaemia |
3.7% |
| Nausea |
3.4% |
| Transient Ischaemic Attack |
3.4% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Haematuria |
3.1% |
| Myocardial Infarction |
3.1% |
| Epistaxis |
2.8% |
| Glioblastoma |
2.8% |
| Cerebral Infarction |
2.5% |
| Death |
2.5% |
|
| Secondary |
| Atrial Fibrillation |
27.9% |
| Hypertension |
14.0% |
| Cerebrovascular Accident Prophylaxis |
13.8% |
| Product Used For Unknown Indication |
10.8% |
| Coronary Artery Disease |
6.3% |
| Diabetes Mellitus |
3.2% |
| Cardiac Failure |
3.1% |
| Prophylaxis |
2.9% |
| Thrombosis Prophylaxis |
2.3% |
| Anticoagulant Therapy |
2.2% |
| Hyperlipidaemia |
1.9% |
| Hypercholesterolaemia |
1.6% |
| Heart Rate Abnormal |
1.5% |
| Hypothyroidism |
1.5% |
| Pain |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Cardiovascular Event Prophylaxis |
1.2% |
| Atypical Mycobacterial Infection |
1.1% |
| Dyslipidaemia |
1.1% |
| Osteoporosis |
1.1% |
|
| Ischaemic Stroke |
10.6% |
| Gastrointestinal Haemorrhage |
8.5% |
| Deep Vein Thrombosis |
7.0% |
| Rectal Haemorrhage |
7.0% |
| Glioblastoma |
6.3% |
| Thrombocytopenia |
6.3% |
| Cerebrovascular Accident |
5.6% |
| Pulseless Electrical Activity |
5.6% |
| Haemorrhage |
4.9% |
| Myocardial Infarction |
4.2% |
| Toxicity To Various Agents |
4.2% |
| Wound Secretion |
4.2% |
| Pericardial Haemorrhage |
3.5% |
| Renal Impairment |
3.5% |
| Transient Ischaemic Attack |
3.5% |
| Wound Complication |
3.5% |
| Cerebral Haemorrhage |
2.8% |
| Cognitive Disorder |
2.8% |
| Creatinine Renal Clearance Decreased |
2.8% |
| Drug Interaction |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.7% |
| Atrial Fibrillation |
14.9% |
| Hypertension |
7.2% |
| Drug Use For Unknown Indication |
5.9% |
| Prophylaxis |
3.4% |
| Anticoagulant Therapy |
2.9% |
| Diabetes Mellitus |
2.7% |
| Diffuse Large B-cell Lymphoma |
2.7% |
| Parkinson's Disease |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Cerebrovascular Accident Prophylaxis |
0.9% |
| Chronic Lymphocytic Leukaemia |
0.9% |
| Lung Neoplasm Malignant |
0.9% |
| Multiple Myeloma |
0.9% |
| Plasma Cell Myeloma |
0.9% |
| Polyneuropathy |
0.9% |
| Arrhythmia |
0.7% |
| Cerebrovascular Accident |
0.7% |
|
| Cerebrovascular Accident |
8.5% |
| Cardiac Failure |
6.8% |
| Faeces Discoloured |
6.8% |
| Renal Failure Acute |
6.8% |
| Angina Unstable |
5.1% |
| Death |
5.1% |
| Electrolyte Imbalance |
5.1% |
| Ischaemic Stroke |
5.1% |
| Myocardial Infarction |
5.1% |
| Pleural Effusion |
5.1% |
| Pneumonia |
5.1% |
| Pulmonary Embolism |
5.1% |
| Septic Shock |
5.1% |
| Ventricular Tachycardia |
5.1% |
| Atrial Fibrillation |
3.4% |
| Drug Ineffective |
3.4% |
| Dyspnoea |
3.4% |
| Gait Disturbance |
3.4% |
| Incorrect Storage Of Drug |
3.4% |
| Left Ventricular Dysfunction |
3.4% |
|
| Interacting |
| Atrial Fibrillation |
31.3% |
| Product Used For Unknown Indication |
19.3% |
| Epilepsy |
7.2% |
| Hypertension |
7.2% |
| Cerebrovascular Accident Prophylaxis |
6.0% |
| Intracardiac Thrombus |
4.8% |
| Prophylaxis |
3.6% |
| Benign Prostatic Hyperplasia |
2.4% |
| Blood Pressure Abnormal |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Hyperlipidemia |
2.4% |
| Abdominal Pain Upper |
1.2% |
| Anticoagulant Therapy |
1.2% |
| Arrhythmia |
1.2% |
| Constipation |
1.2% |
| Diabetes Mellitus |
1.2% |
| Diarrhoea |
1.2% |
| Diuretic Therapy |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Urinary Tract Infection |
1.2% |
|
| Gait Disturbance |
10.0% |
| Rectal Haemorrhage |
10.0% |
| Rib Fracture |
10.0% |
| Alopecia |
5.0% |
| Drug Level Increased |
5.0% |
| Gastrointestinal Haemorrhage |
5.0% |
| Haematuria |
5.0% |
| Hepatitis |
5.0% |
| Overdose |
5.0% |
| Pleural Haemorrhage |
5.0% |
| Pulmonary Alveolar Haemorrhage |
5.0% |
| Pulmonary Embolism |
5.0% |
| Spontaneous Haematoma |
5.0% |
| Swelling |
5.0% |
| Thrombocytopenia |
5.0% |
| Upper Gastrointestinal Haemorrhage |
5.0% |
| Urogenital Haemorrhage |
5.0% |
|
